What India's Pharma & Cosmetics Corporations Say About Advocate Srijan Tiwari

“When our Mumbai-headquartered company faced an NSQ prosecution at Delhi, we needed someone who truly understood both the law and the science. Most advocates treat these as routine criminal matters — Advocate Tiwari's grasp of analytical testing standards, Form 29 procedures, and pharmacopoeial specifications was exceptional. The case was dismissed at trial level itself, saving us immense reputational and financial damage. His preparation was meticulous, and his cross-examination of the government analyst was the best courtroom work I have witnessed in 20 years of corporate legal work.”

“Our Hyderabad-based API manufacturing facility faced a CDSCO enforcement action with severe commercial implications. Engaging a Delhi High Court specialist was not optional — it was essential. Advocate Tiwari's understanding of CDSCO procedures and his ability to present complex pharmaceutical chemistry arguments in court was remarkable. He guided us through the entire challenge process, secured an interim stay within days, and ultimately the enforcement action was set aside. For any pharma company from South India with a Delhi HC matter, he is the only name I would recommend.”

“We have retained Advocate Tiwari on a standing basis for three years from our Hyderabad office. During that time, he has helped us navigate multiple show cause notices, two NSQ prosecution matters at district court level, and one writ petition at Delhi HC challenging a licence restriction. His turnaround time is exceptional — he responds to urgent matters within hours, not days. His clarity of legal advice — never telling you what you want to hear, always telling you what is accurate — makes him the definitive choice for pharmaceutical corporates across India.”

“Our Gujarat manufacturing licence was suspended without adequate notice. Advocate Tiwari filed a writ petition at the Delhi High Court within 48 hours of receiving our instructions. The stay was granted within a week, and the Full Bench ultimately directed reinstatement with a strong observation about the authority exceeding its powers. For a Gujarat-based manufacturer dealing with central regulatory bodies in Delhi, having a specialist of his calibre at Delhi HC was absolutely decisive. The speed, the quality of the petition, and the outcome were all beyond our expectations.”

“As a Bengaluru-based multinational cosmetics brand, reputational risk from drug law matters is amplified. When we received an NSQ notice for one of our imported cosmetic lines, we needed an advocate who understood both Indian drug law and international product standards. Advocate Tiwari not only handled the defence impeccably but also advised us on CDSCO procedures for imported cosmetics that our internal team was not fully familiar with. We have now made him a permanent part of our India legal panel across all regulatory matters at Delhi.”

“I was initially sceptical of engaging a specialist advocate when a local lawyer offered to handle our NSQ matter at a lower fee. After a disastrous first appearance where the general advocate could not explain the pharmacopoeial standards to the magistrate, we switched to Advocate Srijan Tiwari. The difference was night and day. He took over the matter, filed a detailed technical defence, and within two more hearings secured discharge for all company officers. His fee is absolutely worth every rupee for any Baddi or Himachal pharma company facing a drug law prosecution at Delhi.”

“Our Chennai-based distribution group faced simultaneous NSQ prosecutions in Delhi courts over a two-year period. Advocate Tiwari managed all three matters concurrently, maintaining a consistent legal strategy while adapting arguments to each individual set of facts. The physical distance between Chennai and Delhi was never a barrier — his communication was impeccable and we were always fully informed. Two of the three cases have been decided in our favour, and the third is on track. Managing that complexity from across the country is something very few advocates can do.”

“The value Advocate Tiwari provided in responding to a CDSCO show cause notice went far beyond drafting a legal response. He helped us understand what the central authority was actually looking for, what our strongest defence position was, and how to frame our quality data to best effect. His response successfully averted what could have been a full prosecution for our Haridwar facility. We now involve him at the show cause notice stage in every regulatory matter — which has significantly reduced our prosecution risk.”

“Navigating BIS certification requirements for our Mumbai-based cosmetics range was proving to be a complex regulatory exercise. Advocate Tiwari helped us structure our compliance approach, advised on the legal requirements under the Cosmetics Rules 2020, and drafted our response to a show cause notice arising from a product categorisation dispute. The matter was resolved without reaching prosecution stage. His knowledge of the cosmetics-specific regulatory landscape at the Delhi level is comprehensive and practically oriented.”

“Our Pune-based company faced a situation where the drug authority classified one of our nutraceutical products as a drug requiring a full drug licence. This boundary issue is deeply technical and legally nuanced. Advocate Tiwari handled the Delhi High Court challenge with impressive depth — he understood both the regulatory classification principles and the product composition issues involved. His writ petition successfully established that our product was correctly classified outside the drug category. This precedent has helped us defend similar products in future regulatory interactions across India.”